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ABSTRACT
Re ports from re cent stud ies in di cate a causal re la tion ship be tween allotransfusion, in fec tious com pli ca tions
and re cur rent dis ease in sur gi cal pa tients. The aim of the pre sented study is to elu ci date the pos si bil i ties and
in di ca tions for autologous haemotransfusion in the elec tive sur gery of the colorectal can cer. Ret ro spec tive
anal y sis was per formed over 724 elec tively op er ated pa tients with colorectal can cer. The pro spec tive part in -
cludes ob ser va tion of 20 rad i cally op er ated pa tients. In these pa tients autologous haemotransfusion was per -
formed. As in di ca tions for autologous haemotransfusion we con sider age up to 80 years, he mo glo bin lev els at
least 130 g/l, plas ma pro tein > 65 g/l, bod y weight > 50 k g, good gen  eral con di tion and ab  sence of
decompensated car dio vas cu lar or en do crine dis eases. In two pa tients with he mo glo bin level be tween 90 – 110
g/l we per formed stim u la tion by means of Erythropoetin a. Ac cord ing to ret ro spec tive data ad mis sion he mo -
glo bin lev els var ies from 54 g/l to 175 g/l (mean 119 g/l ± 22, 6). From all elec tively op er ated pa tients 33, 9%
had he mo glo bin val ues over 130 g/l. The fre quency of post op er a tive in fec tious com pli ca tions in creases from
9,1% in nontransfused pa tients to 38,7 % in pa tients with more than 4 units of allogenic blood trans fused. The
pro spec tive part of the study is de signed to es tab lish fea si bil ity of the autologous haemotransfusion in clin i cal
prac tice. The fall of he mo glo bin val ues on the next day af ter do na tion var ies from 11g/l to 19g/l (mean 15.5 g/l
± 2,19). Erythropoetin stim u la tion was not found to in crease he mo glo bin val ues sig nif i cantly. There were no
com pli ca tions in the post op er a tive pe riod in autologous haemotransfusion group with ex cep tion of one su per -
fi cial wound in fec tion. Autologous haemotransfusion is fea si ble in ap prox i mately 1/3 of elec tively op er ated
pa tients with colorectal can cer with no ad verse ef fects or post op er a tive com pli ca tions. It de creases the ne ces -
sity of allogenic bioproducts and hence the risks re lated. Autologous haemotransfusion is easy to per form and
pro pose ben e fits both from med i cal and lo gis tic na ture. Con cern ing to stim u la tion with Erythropoetin in our
opin ion it is with out proven short term ef fi cacy in gen eral sur gery so far. 
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INTRODUCTION
The de vel op ment of ab dom i nal onkosurgery and es pe cially 
the elec tive op er a tive treat ment of colorectal can cer are im -
pos si ble with out use of blood and blood prod ucts to day.
Un for tu nately in re cent years of clin i cal prac tice some ev i -
dence emerged for ad verse ef fects of allogenic blood trans -
fu sions (1). Blood trans fu sion-in duced im pair ment of the
im mune re sponse may re duce re sis tance to bac te rial in fec -
tion and tu mor growth. Re ports from clin i cal stud ies in di -
cate a causal re la tion ship be tween allotransfusion, in fec -
tious com pli ca tions and re cur rent dis ease (2,3). On the
other side the pos si bil ity of HIV in fec tion, hep a ti tis and
graft-ver sus-host re ac tions can not be avoided com pletely
al though allogenic trans fu sion has be come a safer pro ce -
dure as a re sult of better screen ing. Con sid er able prob lem
in our coun try had be come in suf fi cient num ber of healthy,
will ing do nors and sup ply with ad e quate amount of blood
re spec tively. 
One of the pos si ble so lu tions of this prob lem is the use of
autologous haemotransfusion in elec tive colorectal sur gery
(4,5). In the United States the method has been de vel oped
ac tively in the mid dle 1980s as a re sult of AIDS panic and
to day nearly 5% of blood trans fused is autologous. In
West ern Eu rope and Ja pan autologous haemotransfusion
be came pop u lar re cently in the field of ab dom i nal sur gery
be cause of the sort pe riod from the di ag no sis of can cer to
the op er a tion and fre quent pres ence of ane mic syn drome
(6).
Our in ten tion is to an swer whether autologous
haemotransfusion is a method ap pro pri ate for our clin i cal
prac tice with pa tients al lo cated for elec tive sur gery due to
colorectal can cer. Are there some dif fi cul ties or com pli ca -
tions re lated to this method and is it pos si ble to avoid
allogenic trans fu sion and when? 
Now a days there are tree main tech niques for autologous
haemotransfusion – predeposit trans fu sion, acute
normovolemic haemodilution and intra- and post op er a tive
blood sal vage (7). 
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In acute normovolemic haemodilution ap prox i mately 1 li -
ter whole blood is re moved be fore the op er a tion is started
and si mul ta neously intravascular vol ume is re placed with
colloid, crystalloid or both. The blood is then reinfused dur -
ing the op er a tion. The method is hardly to per form in real
cir cum stances be cause of ad di tional ex pe ri ence of the an -
es thetic team needed, ex penses and poor stud ied risks for
the pa tient so far.
Intra- and post op er a tive blood sal vage is the old est method
used. Its dis ad van tages are need for elab o rate in stru ments
and risk for co ag u la tion and elec tro lyte dis tur bances. The
most im por tant of them is that colorectal sur gery is
clean-con tam i nated pro ce dure and the risk for bac te rial
con tam i na tion of op er a tive field and col lected blood is al -
ways pre sented. 
Be cause of dis ad van tages de scribed above we de cided to
use the first method - predeposit trans fu sion (8) as we think
it is safer and easy to per form.
AIM
The aim of the pre sented study is to elu ci date the pos si bil i -
ties and in di ca tions for autologous haemotransfusion in the
elec tive sur gery of the colorectal can cer. The main ques tion 
to be an swered is whether the method can be used rou tinely 
in our clin i cal prac tice and what is the ben e fit for the pa -
tients.
MATERIALS AND METHODS: 
In or der to ac com plish the aim of the study ret ro spec tive
anal y sis of the ad mis sion he mo glo bin lev els be fore sur -
gery, the need for haemotransfusion and its cor re la tion with 
post op er a tive in fec tious com pli ca tions rate was done. Ret -
ro spec tive anal y sis was per formed over 724 pa tients op er -
ated in our Clinic elec tively due to colorectal can cer for the
last 10 years. 
The age of the pa tient in cluded in ret ro spec tive study var ies 
from 22 to 92 years - (mean 63, 1 ± 10, 5). Al lo ca tion by
gen der is: men 409 (56.5%) women 315 (43.5 %). Pa tients
with colorectal can cer are strat i fied by ТNМ (9) as: Stage 0
– 0, 3%, І st. – 16.5%, ІІ Stage – 52.2 %, ІІІ Stage 10.7%,
ІV Stage – 19.8 % and in 0,5 % - there is not enough ev i -
dence to de fine the stage.
The pro spec tive part of the study in cludes ob ser va tion of 20 
rad i cally op er ated pa tients due to colorectal can cer in last
18 months. In these pa tients autologous haemotransfusion
was per formed. All of the pa tients were di ag nos ti cally eval -
u ated be fore sur gery by means of en dos copy or bar ium en -
ema, ab dom i nal echography and/or CT and were biopsied.
The age of the pa tients in cluded var ies from 47 to 69
години - (mean 56, 5 ± 8, 4). Al lo ca tion by gen der is: men
13 (65 %) women 7 (35 %). All of the pa tients in cluded
were in I or II clin i cal stage of the neo plas tic dis ease. 
As in di ca tions for autologous haemotransfusion we con -
sider age un der 80 years, plasma pro tein > 65 g/l, body
weight > 50 kg, good gen eral con di tion and the ab sence of
decompensated car dio vas cu lar or en do crine con com i tant
dis eases. Con cern ing the most im por tant in di ca tor – blood
he mo glo bin – we adopted ex tremely con ser va tive ap -
proach and de fined val ues at least 130 g/l as an in clu sion
fac tor for autologous do na tion. 
No pa tient had se vere com pli ca tions be fore the op er a tion
and none of them had re ceived pre op er a tive che mo ther apy
or ra dio ther apy.
The autologous blood trans fu sion pro gram in volved one or
two do na tions of 450 ml each ac cord ing to he mo glo bin
lev els. In ter val be tween do na tions and op er a tion should be
no less than 3 days. Do nated amount was stored as liq uid
whole blood till the mo ment of use. 
We an a lyze the fall in he mo glo bin val ues on the day af ter
each do na tion of autologous blood.
In two pa tients with he mo glo bin level be tween 90 – 110 g/l 
we per formed stim u la tion of erythropoesis by means of
Erythropoetinα, twice of 5000 IU be tween 5 days in tra ve -
nously in com bi na tion with Venofer one vial daily. 
Sta tis ti cal anal y sis was per formed with the use of SPSS
soft ware.
RESULTS AND DISCUSSION
The ab sence of ane mic syn drome in pa tients pre pared for
sur gery is pre sum ably of main sig nif i cance for ac com plish -
ing an autologous do na tion. It is clear that not ev ery pa tient
is suit able for such a pro ce dure. From this point of view it is 
im por tant to know the ad mis sion he mo glo bin lev els in pa -
tients with colorectal can cer and what is the per cent of them 
with ap pro pri ate val ues. 
Study ing ret ro spec tive data for the last 10 years we re -
ceived fol low ing re sults: ad mis sion he mo glo bin level in
our pa tient var ies be tween 54 g/l and 175 g/l (mean 119 g/l
± 22, 6). Re sults are shown in Di a gram №1. 
From the pre sented di a gram it is clear that he mo glo bin val -
ues of the pa tients with colorectal can cer be fore op er a tive
treat ment are highly vari able. It is im por tant to point the
fact that not all of pa tients were with pro found ane mic syn -
drome. There is a sig nif i cant part of them with ad mis sion
he mo glo bin lev els re main ing in the ref er ent val ues for age
and gen der.
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Diagram № 1. Distribution of the patients according to
admission hemoglobin levels
Much more im por tant is the next find ing, that 33, 9% from
all elec tively op er ated pa tients due to colorectal can cer had
ad mis sion he mo glo bin lev els over 130 g/l. There fore
autologous haemotransfusion is fea si ble ap prox i mately in
1/3 of the pa tients. Fur ther de ci sion to un der take or not an
autologous do na tion should be made in di vid u ally ac cord -
ing to gen eral con di tion, pres ence of con com i tant dis eases,
stage of the neo plas tic dis ease and vol ume of op er a tion ex -
pected. 
On the next Di a gram №2 the cor re la tion be tween stage of
the neo plas tic dis ease in TNM scale and per cent of the pa -
tients with ad mis sion he mo glo bin lev els over 130 g/l is pre -
sented in de tails. It is ob vi ous that pa tients in early stages of
the dis ease are more suit able for the autologous
haemotransfusion be cause of higher pro por tion nonanemic
in di vid u als. It could be ar gued that some of them do not
need haemotransfusion at all. In our opin ion the method is
use ful op tion in ev ery pa tient even ex pected op er a tion is
with out great blood loss. We take in con sid er ation some
rea sons:
• Rel a tive pre op er a tive haemodilution is ad di tive fac tor
for pro phy laxis of throboembolis com pli ca tions.
• Fresh liq uid blood re tains its haemostatic prop er ties –
plate lets and co ag u la tion fac tors.
• Com pletely re places intravascular vol ume and thus
elim i nates the need for allogenic plasma trans fu sion
or/and Humanaalbum.
• Gives a safety that bioproduct is avail able in cases with
rare blood groups – cir cum stance that fre quently leads
to de lay of the op er a tion planed when a def i cit of such
blood group is pres ent in lo cal hemotransfusiology
cen ter. 
An other im por tant find ing from the ret ro spec tive anal y sis
is that the more amount of allogenic blood units were trans -
fused the more fre quency of post op er a tive in fec tious com -
pli ca tions were ob served in the op er ated pa tients. 
It is clear that the fre quency of post op er a tive in fec tious
com pli ca tions of the op er a tive wound in creases from 9,1 % 
in nontransfused pa tients to 38,7 % in pa tients with more
than 4 units of allogenic blood trans fused. There is also a
clear trend to ward in creased in fec tious wound com pli ca -
tions rate with raise of the to tal amount of blood trans fused.
Hence, the allogenic blood trans fu sions should be con -
cerned as a risk fac tor for de vel op ment of post op er a tive in -
fec tious com pli ca tions in elec tive colorectal sur gery.
The pro spec tive part of the study is de signed to es tab lish
fea si bil ity of the autologous haemotransfusion in clin i cal
prac tice. From this point of view is es sen tial to eval u ate the
in flu ence of 450 ml whole blood do na tion over the he mo -
glo bin level of the pa tient sev eral days be fore elec tive sur -
gery planed. It is ob vi ous that the perioperative risk should
not be in creased in any case af ter such a do na tion. On the
fol low ing ta ble № 1 is shown how many de creases he mo -
glo bin level in our pa tients mea sured 24 hours af ter auto
do na tion.








Hb g/l 20 11 g/l 19 g/l 15.50 g/l 2.188
Valid N 20
It is ob vi ous from the ta ble that de po si tion of 450 ml whole
blood sev eral days be fore sur gery do not bring ad di tional
risk for ane mia for se lected pa tients. In part of them is com -
pletely per mis si ble do na tion of two por tions of 450 ml be -
tween 5 – 7 days. The goal is to achieve he mo glo bin lev els
no less than 110 – 115 g/l be fore the start of the op er a tion.
Re sults in Ta ble № 1 and also the data from the ret ro spec -
tive study con firm that autologous haemotransfusion is
pos si ble with out risk ap prox i mately in 1/3 of the pa tients
al lo cated for elec tive colorectal can cer sur gery.
From Di a gram №1 might be con cluded that there is a con -
sid er able group of pa tients with mar ginal he mo glo bin lev -
els from 100 g/l to 120 g/l. In these pa tients is im pos si ble to
per form autologous haemotransfusion with out risk from
un de sired ad di tional ane mia. That was the rea son to ex -
plore the ways for stim u la tion of erythropoesis as it was
pro posed from some au thors in re cent years (10).
Pre op er a tive stim u la tion with Erythropoetin α as de scribed
above was per formed in two pa tients. On the 14 day from
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Diagram № 2. Distribution of the patients with
admission hemoglobin levels over 130 g/l in TNM scale.
Diagram № 3. Relation between amount of blood
transfused and postoperative infectious complications
rate.
the start of the stim u la tion un for tu nately was not found sig -
nif i cant in crease in he mo glo bin value of the pa tients. They
have been ex cluded from autohaemotransfusion group.
Sim i lar re sults was re ported and from other ex plor ers. Ac -
cord ing to them clin i cal ef fi cacy may to be ex pected only in 
se lected pa tients with high iron bioavaiabillity and for lon -
ger pe riod of stim u la tion (11). It have to be taken in con sid -
er ation also the high price of the med i ca tion needed and the
fact that ex penses for the use of Erythropoetin in gen eral
sur gery is not in sured by the Na tional Health Fund so far.
There were no com pli ca tions in the post op er a tive pe riod in
autologous haemotransfusion group with ex cep tion of one
su per fi cial wound in fec tion. 
CLINICAL CASES
А.С. 65 years >. Very good gen eral con di tion. Dg: Ca
rectosigmoidalis, T3, N0, M0. His tol ogy – mod er ate to low
dif fer en ti ated adenocarcinoma. Ad mis sion he mo glo bin
level 166 g/l. Two do na tions of 450 ml whole blood each
be tween 4 days. Af ter the first do na tion Hb 155 g/l. Pre op -
er a tively 138 g/l. Op er a tion: RRA. One unit autologous
blood intraoperatively. On the third post op er a tive day –
one more unit. Un event ful post op er a tive pe riod. With out
trans fu sion of other bioproducts. On dis charge – Hb 136
g/l.
К.Д. 62 years. +. Very good gen eral con di tion. Dg: Ca
recti. T1, N0, M0. His tol ogy – highly dif fer en ti ated
adenocarcinoma. Ad mis sion he mo glo bin level 133 g/l. One 
do na tion of 450 ml whole. Pre op er a tively 117 g/l. Op er a -
tion: RRA. One unit autologous blood intraoperatively.
Un event ful post op er a tive pe riod with trans fu sion of two
units fresh frozen plasma. On dis charge - 84 g/l. Be cause
the ab sence of com pli ca tions allotransfusion was not per -
formed. Dis charged with pre scribed per oral iron med i ca -
tion. Con trol ex am i na tion af ter tree months – Hb in ref er -
ence.
CONCLUSION
The method of autologous haemotransfusion is fea si ble in
ap prox i mately 1/3 of elec tively op er ated pa tients with
colorectal can cer mainly in I and II clin i cal stage. There are
no ad verse ef fects and post op er a tive com pli ca tions due to
the method. It con sid er ably de creases the ne ces sity of
allogenic bioproducts and hence the risks re lated.
Autologous haemotransfusion is easy to per form in clin i cal
prac tice and pro pose ben e fits both from med i cal and lo gis -
tic na ture. 
Con cern ing to stim u la tion with Erythropoetin in our opin -
ion it is rather ex pen sive and with out proven short term ef -
fi cacy in gen eral sur gery so far. 
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